BIOMAT Database Logo BIOMAT Database Logo

N(14)-substituted evodiamine derivatives as dual topoisomerase 1/tubulin-Inhibiting anti-gastrointestinal tumor agents. 2023

Jiedan Deng, and Lin Long, and Xue Peng, and Weifan Jiang, and Ying Peng, and Xi Zhang, and Yuting Zhao, and Ying Tian, and Zhen Wang, and Linsheng Zhuo
School of Pharmacy, Lanzhou University, Lanzhou, 730000, China.

Gastrointestinal tumor is an important factor threatening human health. Natural product-based drug discovery is a popular paradigm for expanding the chemical space and identifying new molecular entities that ameliorate human disease. Evodiamine-inspired medicinal chemistry presents therapeutic potential for treating tumors in different tissues via multi-target inhibition. Here, by focusing on the discovery of anti-gastrointestinal tumor drugs, a series of N(14) alkyl-substituted evodiamine derivatives were designed and synthesized. The structure-activity relationship studies culminated in the identification of the N(14)-propyl-substituted evodiamine analog 6b, which showed low nanomolar inhibitory activity against MGC-803 (IC50 = 0.09 μM) and RKO (IC50 = 0.2 μM) cell lines. Moreover, compound 6b was effective in inducing apoptosis, arresting the cell cycle in the G2/M phase, and inhibiting migration and invasion of MGC-803 and RKO cell lines in a dose-dependent manner in vitro. Further antitumor mechanism studies revealed that compound 6b significantly inhibited topoisomerase 1 (inhibition rate of 58.3% at 50 μM) and tubulin polymerization (IC50 = 5.69 μM). Overall, compound 6b represents a promising dual topoisomerase 1/tubulin-targeting lead structure for the treatment of gastrointestinal tumor.

UI MeSH Term Description Entries
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D050257 Tubulin Modulators Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. Microtubule Modulator,Tubulin Inhibitor,Tubulin Modulator,Tubulin Polymerization Inhibitor,Tubulin Polymerization Promoter,Tubulin Promoter,Microtubule Modulators,Tubulin Inhibitors,Tubulin Polymerization Inhibitors,Tubulin Polymerization Promoters,Tubulin Promoters,Inhibitor, Tubulin,Inhibitor, Tubulin Polymerization,Inhibitors, Tubulin,Inhibitors, Tubulin Polymerization,Modulator, Microtubule,Modulator, Tubulin,Modulators, Microtubule,Modulators, Tubulin,Polymerization Inhibitor, Tubulin,Polymerization Inhibitors, Tubulin,Polymerization Promoter, Tubulin,Polymerization Promoters, Tubulin,Promoter, Tubulin,Promoter, Tubulin Polymerization,Promoters, Tubulin,Promoters, Tubulin Polymerization
D058105 Polymerization Chemical reaction in which monomeric components are combined to form POLYMERS (e.g., POLYMETHYLMETHACRYLATE). Polymerizations

Related Publications

Jiedan Deng, and Lin Long, and Xue Peng, and Weifan Jiang, and Ying Peng, and Xi Zhang, and Yuting Zhao, and Ying Tian, and Zhen Wang, and Linsheng Zhuo
Design, synthesis and bioactivity evaluation of novel N-phenyl-substituted evodiamine derivatives as potent anti-tumor agents.
February 2022, Bioorganic & medicinal chemistry,
Jiedan Deng, and Lin Long, and Xue Peng, and Weifan Jiang, and Ying Peng, and Xi Zhang, and Yuting Zhao, and Ying Tian, and Zhen Wang, and Linsheng Zhuo
Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agents.
February 2013, Bioorganic & medicinal chemistry letters,
Jiedan Deng, and Lin Long, and Xue Peng, and Weifan Jiang, and Ying Peng, and Xi Zhang, and Yuting Zhao, and Ying Tian, and Zhen Wang, and Linsheng Zhuo
Newer N-substituted anthranilic acid derivatives as potent anti-inflammatory agents.
August 2002, European journal of medicinal chemistry,
Jiedan Deng, and Lin Long, and Xue Peng, and Weifan Jiang, and Ying Peng, and Xi Zhang, and Yuting Zhao, and Ying Tian, and Zhen Wang, and Linsheng Zhuo
Novel substituted naphthalen-1-yl-methanone derivatives as anti-hyperglycemic agents.
May 2006, Bioorganic & medicinal chemistry letters,
Jiedan Deng, and Lin Long, and Xue Peng, and Weifan Jiang, and Ying Peng, and Xi Zhang, and Yuting Zhao, and Ying Tian, and Zhen Wang, and Linsheng Zhuo
Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR.
January 2022, European journal of medicinal chemistry,
Jiedan Deng, and Lin Long, and Xue Peng, and Weifan Jiang, and Ying Peng, and Xi Zhang, and Yuting Zhao, and Ying Tian, and Zhen Wang, and Linsheng Zhuo
Novel N-substituted sophoridinol derivatives as anticancer agents.
June 2014, European journal of medicinal chemistry,
Jiedan Deng, and Lin Long, and Xue Peng, and Weifan Jiang, and Ying Peng, and Xi Zhang, and Yuting Zhao, and Ying Tian, and Zhen Wang, and Linsheng Zhuo
Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.
November 2010, Journal of medicinal chemistry,
Jiedan Deng, and Lin Long, and Xue Peng, and Weifan Jiang, and Ying Peng, and Xi Zhang, and Yuting Zhao, and Ying Tian, and Zhen Wang, and Linsheng Zhuo
14-Formyl-15-aryloxy/methoxymatrine and 14-Aryloxymethylidenyl-matrine Derivatives as Anti-HIV-1 Agents.
January 2018, Medicinal chemistry (Shariqah (United Arab Emirates)),
Jiedan Deng, and Lin Long, and Xue Peng, and Weifan Jiang, and Ying Peng, and Xi Zhang, and Yuting Zhao, and Ying Tian, and Zhen Wang, and Linsheng Zhuo
[Antimycotic agents. 7. Nuclear substituted N-(1-adamantyl)-N'-phenylthiourea derivatives].
September 1978, Archiv der Pharmazie,
Jiedan Deng, and Lin Long, and Xue Peng, and Weifan Jiang, and Ying Peng, and Xi Zhang, and Yuting Zhao, and Ying Tian, and Zhen Wang, and Linsheng Zhuo
Adamantane derivatives of thiazolyl-N-substituted amide, as possible non-steroidal anti-inflammatory agents.
March 2009, European journal of medicinal chemistry,
Copied contents to your clipboard!